Pig semen, Piers Morgan and other slightly embarrassing British exports

David Cameron's terribly proud of his £45m sale of porcine semen to China – and why should he be red-faced? Many of Britain's other exports are a lot more ludicrousOne of the great successes of David Cameron's trip to China was an agreement to sell the country £45m-worth of British pig semen. It's good news for British exports in general, but not necessarily a deal you'd care to boast about during prime minister's questions. Of course pig semen is not the only embarrassing export to leave these shores. Here are just a few more.Other kinds of semen The UK exports bovine semen to countries including France, Kenya, Indonesia and Albania. Britain also exports dog semen and horse semen, and imports red-deer semen.Empty boxesRising paper prices have created a lucrative market for recycled cardboard, especially in China. Basically, when China ships a new TV to the UK, we sell them back the box it came in, which they use to make a new box. It's green, efficient and rather canny, but it's a little embarrassing that even our exported empty boxes are being imported back, only full.Bendy busesThe much-maligned bendy bus was removed from London's streets at the end of 2011, but the manufacturer, Arrive, sold a whole fleet to Malta, where they proved just as unpopular. Service was suspended in the summer after three of the buses caught fire.Midsomer MurdersThe Oxfordshire-set murder mystery series has proved popular in the US, Canada and Australia. It's also the most watc...
Source: Guardian Unlimited Science - Category: Science Authors: Tags: The Guardian Blogposts Farming Asia Pacific World news Piers Morgan China Features Crime drama Environment Business Agriculture Science Source Type: news

Related Links:

CONCLUSION: One copy number of GSTM1 and GSTT1 presented a higher frequency among carrier genes, but the CNV of GSTM1 and GSTT1 was not associated with HNC risk. PMID: 30526121 [PubMed - as supplied by publisher]
Source: Biomarkers - Category: Research Tags: Biomarkers Source Type: research
Check-Cap is getting one step closer to having its capsule-based screening method for colorectal cancer on the U.S. market. The Isfiya, Israel-based company has received FDA conditional approval for an IDE to initiate a pilot study of the C-Scan capsule. FDA’s conditional approval of the IDE requires Check-Cap to provide additional information to the agency and the company may begin enrolling patients immediately upon approval by the study site's Institutional Review Board (IRB). The trial will consist of up to 45 patients and it will be a single-arm study. Patients who are enrolled will be those conside...
Source: MDDI - Category: Medical Devices Authors: Tags: Regulatory and Compliance Implants Source Type: news
Source: BMJ News - Category: General Medicine Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
Source: BMJ News - Category: General Medicine Source Type: research
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
Source: BMJ Comments - Category: General Medicine Source Type: forums
More News: Albania Health | Blogging | Environmental Health | Malta Health | Science